Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12,503	10,139	14,927	10,696	6,137	5,639
Short-Term Investments	4,500	7,500	-	3,000	7,000	6,500
Cash & Short-Term Investments	17,003	17,639	14,927	13,696	13,137	12,139
Cash Growth	5.53%	18.17%	8.99%	4.25%	8.22%	-12.66%
Accounts Receivable	2,327	2,855	2,667	1,451	2,130	1,274
Other Receivables	273.96	96.37	55.64	17.55	293.91	219.34
Receivables	2,681	3,331	2,723	1,469	2,424	1,494
Inventory	4,746	4,198	3,852	3,759	2,353	2,110
Prepaid Expenses	145.34	130.07	13.01	343.11	58.1	70.99
Other Current Assets	62.14	268.1	88.1	284.98	413.05	128.57
Total Current Assets	24,638	25,567	21,603	19,552	18,386	15,942
Property, Plant & Equipment	7,873	7,770	8,035	7,285	5,776	1,673
Long-Term Investments	8,058	8,058	8,584	7,233	7,744	6,986
Other Intangible Assets	147.78	131.53	31.03	64.35	101.08	152.42
Long-Term Deferred Tax Assets	1,964	1,842	2,064	2,043	1,780	-
Long-Term Deferred Charges	-	-	-	-	0	71.52
Other Long-Term Assets	855.11	858.17	600.51	723.89	683.35	656.94
Total Assets	43,627	44,275	40,932	36,901	34,469	25,481
Accounts Payable	285.68	97.48	164.9	134.26	144.46	278.44
Accrued Expenses	279.68	234.02	130.05	277.79	150.37	143.95
Current Portion of Long-Term Debt	-	-	3,900	-	-	-
Current Portion of Leases	165.94	173.94	175.47	235.32	214.76	211.59
Current Income Taxes Payable	-	79.88	77.4	87.32	-	-
Current Unearned Revenue	-	-	9.86	-	-	-
Other Current Liabilities	1,274	1,311	780.35	598.52	907.73	585.46
Total Current Liabilities	2,005	1,896	5,238	1,333	1,417	1,219
Long-Term Debt	2,400	2,400	-	3,900	3,900	-
Long-Term Leases	294.48	389.6	587.61	243.97	320.97	916.77
Pension & Post-Retirement Benefits	4,011	3,760	3,510	2,422	1,741	1,611
Other Long-Term Liabilities	231.94	335.45	284.31	152.49	98.52	270.52
Total Liabilities	8,944	8,781	9,620	8,052	7,477	4,017
Common Stock	7,189	7,189	7,189	3,595	3,595	3,595
Additional Paid-In Capital	22,646	22,646	22,646	26,259	26,259	26,259
Retained Earnings	6,287	5,851	1,680	-1,202	-2,936	-8,449
Comprehensive Income & Other	-442.26	-191.59	-203.85	197.9	74.85	59.14
Shareholders' Equity	34,683	35,494	31,311	28,850	26,992	21,464
Total Liabilities & Equity	43,627	44,275	40,932	36,901	34,469	25,481
Total Debt	2,860	2,964	4,663	4,379	4,436	1,128
Net Cash (Debt)	14,143	14,676	10,264	9,317	8,701	11,010
Net Cash Growth	22.47%	42.98%	10.17%	7.07%	-20.97%	-12.74%
Net Cash Per Share	990.57	1020.63	713.81	647.93	605.15	1058.68
Filing Date Shares Outstanding	14.06	14.38	14.38	14.38	14.38	14.38
Total Common Shares Outstanding	14.06	14.38	14.38	14.38	14.38	14.38
Working Capital	22,633	23,671	16,365	18,219	16,968	14,722
Book Value Per Share	2467.08	2468.50	2177.60	2006.39	1877.21	1492.72
Tangible Book Value	34,535	35,363	31,280	28,785	26,891	21,311
Tangible Book Value Per Share	2456.56	2459.36	2175.44	2001.92	1870.18	1482.12
Land	1,557	1,557	1,557	-	1,557	-
Buildings	2,974	2,974	2,974	-	2,974	-
Machinery	2,865	2,734	2,502	-	2,001	1,780
Construction In Progress	2,575	2,338	2,278	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.